Minimal residual disease was “strongly” associated with overall survival at the patient level, researchers reported. Minimal residual disease (MRD) is “a credible intermediate endpoint” for some ...
Those with longer moto memories may recognize the silhouette of the Suzuki on this page, which has roots dating back to the millennium. In the year 2000, the Japanese manufacturer began producing the ...
In vivo CAR T-cell therapy could revolutionize cancer treatment by bypassing traditional manufacturing, reducing costs, and minimizing adverse events. Kelonia Therapeutics' KLN-1010 has shown ...
Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable residual disease (MRD), may provide an early and reliable indicator of long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results